Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

GBS/CIDP Research Grant Program

GBS/CIDP Foundation International

Research is Critical To Serving The Cause and The Community

The GBS|CIDP Foundation International believes in supporting research on GBS, CIDP, and variants by funding grants for projects that contribute to the knowledge of, and towards an eventual cure for, GBS, CIDP, and variants.

To date, we have committed $8 million towards basic and translational research.

As part of the GBS|CIDP Foundation International’s mission to provide education and support research, we offer research grants to qualified applicants. Grants are made possible through the benevolence of many sources, including the Helen S. Manheimer Research Fund, contributions from individuals who have been personally touched by GBS, CIDP, or variants, and by several commercial sources. Through the generosity of these contributors, to whom the Foundation is most grateful, we are able to offer a Research Grant Program. The GBS|CIDP Foundation International has worldwide representation, sharing resources with local support group chapters nationally and internationally.

GBS|CIDP Foundation International: Types of Grants Awarded

Foundation funding interests include GBS, both demyelinating and axonal variants, Miller Fisher syndrome, CIDP, Multifocal Motor Neuropathy, and others. Research interests cover a broad range of subjects including development of methods to more rapidly diagnose these disorders, creation of educational and communication programs to inform patients and families of the Foundation’s availability, identification of mechanisms involved in the pathogenesis of family disorders, development of more effective treatments to limit the disease process, prevent complications and reduce long-term adverse sequelae.

Letter of Intent Procedure: Step One

Applicants should submit a one-page Letter of Intent by November 1.

The Letter should contain the following information:

Title of the project, Name and Title of Investigator(s) along with their contact information (department and institution name, address, phone number, and email address) and a synopsis of the proposal not to exceed 300 words.
The letter should be typed in 12 point, Times Roman font, with 1” margins. A PDF file shouldbe submitted to the organization by email or uploaded using the online form.
Receipt of the letter will be acknowledged by email and notification by email to submit or not submit a full application will be made by December 15.

Please submit your letter of intent to Member Services Manager, Lori.basiege@gbs-cidp.org.

Application Procedure and Deadlines

November 1	Letter of Intent
December 15	Notification of Grant Status and Full Application
January 31	Full Application Deadline by Midnight
March 15	Grant Committee Reviews Full Applications
April 15	Presentation by Grant Committee to Board of Directors for Approval
May 30	Announcement of Awards
June 1	First installment payout to Awardee(s)

*If an application is approved for funding the applicant should submit institutional approval for animal or/ and human subject studies prior to disbursement of Grant Funds.*

Specialties

Neurosciences

Others

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: GBS/CIDP Foundation International

Sponsor Type:

Address: 375 East Elm Street, Suite 101, Conshohocken, PA 19428 | Phone: 866-224-3301

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity